About Cipla
Back in 1935, when Khwaja Abdul Hamied founded the company, Cipla was known as _______________________________.
The Chemical, Industrial & Pharmaceutical Laboratories
In the pharma industry, patents are generally awarded for ___ years.
Actelion Pharmaceuticals Ltd. was acquired by ___________ in June 2017. Actelion’s products for pulmonary arterial hypertension complements this company’s current portfolio.
Johnson & Johnson
Higher spending on R&D, owing to Products Patents have made India a major destination for ___________ drug manufacturing and is expected to benefit the Indian pharmaceutical companies.
generic
In Feb 2018, Cipla tied up with its once bitter pharma rival, _______ to market anti-cancer drugs.
Roche Pharma
The Government of India aims to make India a global leader in end-to-end drug manufacturing by year ________.
2020 (Pharma vision 2020)
In 2017 the U.S. Food and Drug Administration approved the first CAR-T cell therapy for cancer. Which company does the drug belong to?
Novartis
For the period between FY 2018 to FY 2020, ICRA, a professional investment information and credit rating agency predicts that the pharma industry is projected to grow at _______ per cent after mid to high double-digit growth over the last five years.
7-10
In 2014, the UN-backed Medicines Patent Pool signed six sub-licenses with these companies to make generic anti-AIDS medicine, TenofovirAlafenamide (TAF) for 112 developing countries. Name the companies.
Aurobindo, Cipla, Desano, Emcure, Hetero Labs and Laurus Labs
This company launched the first pharma-led ResearchKit study. The study was to collate data on the impact a patient’s disease has on their day-to-day life. The study was called, PARADE, which stands for Patient Rheumatoid Arthritis Data in the Real World. Name the company.
GlaxoSmithKline